BackRadiopharm Theranostics Limited Overview

Radiopharm Theranostics Limited Total Liabilities

Track Radiopharm Theranostics Limited's total liabilities ($38M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$37.81M

Peer trimmed avg / median

Loading

Radiopharm Theranostics Limited Total Liabilities History

Loading

Radiopharm Theranostics Limited vs. peers: Total Liabilities Comparison

Loading

Radiopharm Theranostics Limited Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Radiopharm Theranostics Limited (RADX) FAQ

Radiopharm Theranostics Limited's total liabilities stands at $38M as of June 2026. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether Radiopharm Theranostics Limited's total liabilities is expanding or contracting. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Radiopharm Theranostics Limited's total liabilities evolved across reporting periods, while the comparison chart places RADX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total liabilities is commonly used to spot outliers. Radiopharm Theranostics Limited's reading of $38M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.